136 related articles for article (PubMed ID: 38681690)
1. Evaluation of Histopathologic Findings and Safety of Intravitreal Ketamine Administration on Vitreoretinal Tissue in Rat Model: A Pilot Study.
Sanatkar M; Nozarian Z; Abdi P; Bazvand F
J Curr Ophthalmol; 2023; 35(3):297-300. PubMed ID: 38681690
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal ketamine promotes neuroprotection in rat eyes after experimental ischemia.
Dourado LFN; Oliveira LG; da Silva CN; Toledo CR; Fialho SL; Jorge R; Silva-Cunha A
Biomed Pharmacother; 2021 Jan; 133():110948. PubMed ID: 33249278
[TBL] [Abstract][Full Text] [Related]
3. Acute Sterile Endophthalmitis Following Intravitreal Rituximab Injection in Primary Vitreoretinal Lymphoma: Case Series.
Guneri Beser B; Demirci H
Ocul Immunol Inflamm; 2023 Mar; ():1-6. PubMed ID: 36952513
[TBL] [Abstract][Full Text] [Related]
4. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Zhou N; Xu X; Liu Y; Wang Y; Wei W
Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal evaluation of immediate inflammatory responses after intravitreal AAV2 injection in rats by optical coherence tomography.
Liu YF; Huang S; Ng TK; Liang JJ; Xu Y; Chen SL; Xu C; Zhang M; Pang CP; Cen LP
Exp Eye Res; 2020 Apr; 193():107955. PubMed ID: 32017940
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study.
Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M
Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385
[No Abstract] [Full Text] [Related]
8. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
9. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
10. Efficient vitreolysis by combining plasmin and sulfur hexafluoride injection in a preclinical study in rabbit eyes.
Wu WC; Liu CH; Chen CC; Wang NK; Chen KJ; Chen TL; Hwang YS; Li LM; Lai CC
Mol Vis; 2012; 18():2361-70. PubMed ID: 23049236
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma.
Tsai JC; Wu L; Worgul B; Forbes M; Cao J
Curr Eye Res; 2005 Nov; 30(11):1025-31. PubMed ID: 16282136
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal injection of endothelin-1 caused optic nerve damage following to ocular hypoperfusion in rabbits.
Sasaoka M; Taniguchi T; Shimazawa M; Ishida N; Shimazaki A; Hara H
Exp Eye Res; 2006 Sep; 83(3):629-37. PubMed ID: 16677631
[TBL] [Abstract][Full Text] [Related]
13. Histopathologic effects of the single intramuscular injection of ketamine, atropine and midazolam in a rat model.
Barrueto F; Salleng K; Sahni R; Brewer KL
Vet Hum Toxicol; 2002 Oct; 44(5):306-10. PubMed ID: 12361123
[TBL] [Abstract][Full Text] [Related]
14. Retinal toxicity of intravitreal trastuzumab in a rabbit model: preliminary results of an experimental study.
Moschos MM; Chatziralli IP; Kalogeropoulos C; Georgountzos V; Agapitos E
J Ocul Pharmacol Ther; 2013 Oct; 29(8):754-9. PubMed ID: 23597072
[TBL] [Abstract][Full Text] [Related]
15. Optic atrophy after anti-vascular endothelial growth factor injection in diabetic patients with proliferative diabetic retinopathy.
Singalavanija A; Hemarat K; Kedkovid N; Tanterdtham J; Namatra C; Trinavarat A; Rodanant N; Thoongsuwan S
J Med Assoc Thai; 2013 Mar; 96(3):318-23. PubMed ID: 23539935
[TBL] [Abstract][Full Text] [Related]
16. Retinal ganglion cell activity from the multifocal electroretinogram in pig: optic nerve section, anaesthesia and intravitreal tetrodotoxin.
Lalonde MR; Chauhan BC; Tremblay F
J Physiol; 2006 Jan; 570(Pt 2):325-38. PubMed ID: 16284074
[TBL] [Abstract][Full Text] [Related]
17. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy.
Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P
Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418
[TBL] [Abstract][Full Text] [Related]
18. Impact of Intravitreal Injection of Bevacizumab (Avastin) on Rabbit's Choroid and Retina.
Karawya S; Said DG; Salaheldin MM; Zaky I
Middle East Afr J Ophthalmol; 2008 Apr; 15(2):67-72. PubMed ID: 21346840
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide, retinal microglia and retinal ganglion cell apoptosis in the optic nerve crush model.
Wang J; Chen S; Zhang X; Huang W; Jonas JB
Acta Ophthalmol; 2016 Aug; 94(5):e305-11. PubMed ID: 25708663
[TBL] [Abstract][Full Text] [Related]
20. Ocular Safety of Intravitreal Connective Tissue Growth Factor Neutralizing Antibody.
Motevasseli T; Daftarian N; Kanavi MR; Ahmadieh H; Bagheri A; Hosseini SB; Ansari S; Soheili ZS
Curr Eye Res; 2017 Aug; 42(8):1194-1201. PubMed ID: 28494166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]